Summary Safety Review - GARDASIL (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) - Assessing General Safety with a Focus on Autoimmune and Cardiovascular Diseases
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | |
| Version | |
| Author | |
| Author Email | |
| Maintainer | |
| Maintainer Email | |
| Data Level | |
| Agreement Required | |
| Purpose Constraints | |
| Redistribution Allowed | |
| AI Training Allowed | |
| Data Steward | |
| Title (French) | Résumé de l'examen de l'innocuité - GARDASIL (vaccin recombinant quadrivalent contre le virus du papillome humain [types 6, 11, 16 et 18]) - Évaluation de l'innocuité générale et du risque de maladies auto immunes et cardiovasculaire |
| Update Frequency | as_needed |
| Geographic Scope | [] |
| Criticality Level | [] |
| Sensitivity Level | unrestricted |
| Language | |
| Contact Person | |
| Contact Email | |
| Data Dictionary | |
| Open Canada Date Published | 2017-05-18 00:00:00 |
| Open Canada Date Modified | |
| Open Canada Subject | ["health_and_safety"] |
| Open Canada Keywords | {"fr": ["Examen sommaire de l'innocuité", "Gadolinium", "évaluation", "risque", "accumulation de gadolinium", "cerveau", "système cérébral et nerveux", "effets secondaires neurologiques"], "en": ["Summary Safety Review", "GARDASIL", "all vaccines", "side-effects after vaccination", "Quadrivalent Human Papillomavirus", "Recombinant Vaccine", "assessing general safety", "Autoimmune", "Cardiovascular Diseases", "body's own-defence-system attacks-itself", "autoimmune diseases", "diseases affecting", "heart-and-blood-vessels", "cardiovascular diseases"]} |
| Open Canada Collection | publication |
| Principal Organization | |
| Reference Data | |
| Official Source |